Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure (Q74635651)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

1 reference

P S Macdonald

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A M Keogh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C L Aboyoun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Lund

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Amor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

D J McCaffrey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

924-931

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Predictors of prognosis in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

The paradox of beta-adrenergic blockade for the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Exercise performance and beta-blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

Epidemiology of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900680-9

7 January 2021

10.1016/S0735-1097(98)00680-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10091817%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference